Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-5129 in Treatment Naive Type 2 Diabetes
NCT00212641Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ONO-5129 in type 2 diabetes mellitus (T2DM), sponsored by Ono Pharmaceutical. Started Jun 2005; status: completed.
02
Drugs
ONO-5129
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00212641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212641.